Golden State Wealth Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Golden State Wealth Management, LLC
- $673 Billion
- Q1 2025
A detailed history of Golden State Wealth Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 3,700 shares of LXRX stock, worth $2,664. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,700
Previous 7,400
50.0%
Holding current value
$2,664
Previous $3,000
56733.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LXRX
# of Institutions
139Shares Held
244MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$98 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$28 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.11 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$6.47 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $136M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...